Department of Acute Medicine, University of Tokyo, Tokyo, Japan.
Department of Nephrology and Endocrinology, University of Tokyo, Tokyo, Japan.
Semin Nephrol. 2020 Sep;40(5):489-497. doi: 10.1016/j.semnephrol.2020.08.005.
Acute kidney injury (AKI) is one of the most frequent complications of sepsis. Because sepsis and AKI synergistically worsen the outcomes of critically ill patients, better therapeutics against septic AKI urgently are required. In addition to the complexity of disease mechanisms of both sepsis and AKI, there is substantial regional variation in clinical practice, which further hampers the development of new treatments for septic AKI. To overcome this problem, evidence accumulation is necessary for building the foundation for developing novel septic AKI treatments. This review provides a summary of updated evidence regarding septic AKI from Asian regions.
急性肾损伤(AKI)是脓毒症最常见的并发症之一。由于脓毒症和 AKI 协同作用会使危重症患者的预后恶化,因此迫切需要针对脓毒性 AKI 的更好治疗方法。除了脓毒症和 AKI 的疾病机制的复杂性之外,临床实践中还存在大量的区域性差异,这进一步阻碍了脓毒性 AKI 的新疗法的发展。为了克服这个问题,有必要积累证据,为开发新型脓毒症 AKI 治疗方法奠定基础。本综述提供了亚洲地区脓毒症 AKI 的最新证据总结。